Worldwide variations in the prevalence of symptoms of atopic eczema in the international study of asthma and allergies in childhood


      Background: Little is known about the prevalence of atopic eczema outside Northern Europe. Objectives: We sought to describe the magnitude and variation in the prevalence of atopic eczema symptoms throughout the world. Methods: A cross-sectional questionnaire survey was conducted on random samples of schoolchildren aged 6 to 7 years and 13 to 14 years from centers in 56 countries throughout the world. Those children with a positive response to being questioned about the presence of an itchy relapsing skin rash in the last 12 months that had affected their skin creases were considered to have atopic eczema. Children whose atopic eczema symptoms resulted in sleep disturbance for 1 or more nights per week were considered to have severe atopic eczema. Results: Complete data was available for 256,410 children aged 6 to 7 years in 90 centers and 458,623 children aged 13 to 14 years in 153 centers. The prevalence range for symptoms of atopic eczema was from less than 2% in Iran to over 16% in Japan and Sweden in the 6 to 7 year age range and less than 1% in Albania to over 17% in Nigeria for the 13 to 14 year age range. Higher prevalences of atopic eczema symptoms were reported in Australasia and Northern Europe, and lower prevalences were reported in Eastern and Central Europe and Asia. Similar patterns were seen for symptoms of severe atopic eczema. Conclusions: Atopic eczema is a common health problem for children and adolescents throughout the world. Symptoms of atopic eczema exhibit wide variations in prevalence both within and between countries inhabited by similar ethnic groups, suggesting that environmental factors may be critical in determining disease expression. Studies that include objective skin examinations are required to confirm these findings. (J Allergy Clin Immunol 1999;103:125-38.)



      ISAAC: (International Study of Asthma and Allergies in Childhood)
      To read this article in full you will need to make a payment


      Subscribe to Journal of Allergy and Clinical Immunology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Reid P
        • Lewis-Jones MS
        Sleep difficulties and their management in preschoolers with atopic eczema.
        Clin Exp Dermatol. 1995; 20: 38-41
        • Su JC
        • Kemp AS
        • Varigos GA
        • Nolan TM
        Atopic eczema: its impact on the family and financial cost.
        Arch Dis Child. 1997; 766: 159-162
        • Herd RM
        • Tidman MJ
        • Prescott RJ
        • Hunter JAA
        The cost of atopic eczema.
        Br J Dermatol. 1996; 135: 20-23
        • Schultz Larsen F
        The epidemiology of atopic dermatitis.
        in: Epidemiology of clinical allergy. Monogr Allergy. 31. 1993: 9-28
        • Williams HC
        Is the prevalence of atopic dermatitis increasing?.
        Clin Exp Dermatol. 1992; 17: 385-391
        • Williams HC
        Atopic eczema: we should look to the environment.
        Br Med J. 1995; 311: 1241-1242
        • Burkholter D
        • Schiffer P
        The epidemiology of atopic diseases in Europe—a review.
        Allergy Clin Immunol News. 1995; 7: 113-124
        • Williams HC
        • Burney PGJ
        • Pembroke AC
        • Hay RJ
        Validation of the UK diagnostic criteria for atopic dermatitis in a population setting.
        Br J Dermatol. 1996; 135: 12-17
        • Rothe MJ
        • Grant-Kels JM
        Diagnostic criteria for atopic dermatitis.
        Lancet. 1996; 348: 769-770
        • Schultz Larsen F
        • Diepgen T
        • Svensson Å
        The occurrence of atopic dermatitis in Northern Europe: an international questionnaire study.
        J Am Acad Dermatol. 1996; 34: 760-764
        • Asher MI
        • Keil U
        • Anderson HR
        • et al.
        International study of asthma and allergies in childhood (ISAAC): rationale and methods.
        Eur Respir J. 1995; 8: 483-491
        • Asher MI
        • Anderson HR
        • Stewart AW
        • et al.
        Worldwide variations in prevalence of asthma symptoms: the International Study of Asthma and Allergies in Childhood (ISAAC).
        Eur Respir J. 1998; 12: 315-335
        • Strachan DP
        • Sibbald B
        • Weiland SK
        • et al.
        Worldwide variations in the prevalence of symptoms of allergic rhinoconjunctivitis in children: the International Study of Asthma and Allergies in Childhood (ISAAC).
        Pediatr Allergy Immunol. 1997; 8: 161-176
        • Beasley R
        • Keil U
        • von Mutius E
        • et al.
        Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC.
        Lancet. 1998; 315: 1225-1232
        • International Study of Asthma and Allergies in Childhood
        : University of Münster, Münster1992
        • Larsson P-Å
        • Lidén S
        Prevalence of skin diseases among adolescents 12-16 years of age.
        Acta Dermatovenereol (Stockh). 1980; 60: 415-423
        • Uehara M
        • Saito Y
        Occurrence of infantile atopic dermatitis in a different season.
        Hifu Rinshou. 1987; 29: 37-39
        • Williams HC
        • Burney PGJ
        • Hay RJ
        • et al.
        The UK Working Party’s diagnostic criteria for atopic dermatitis I: derivation of a minimum set of discriminators for atopic dermatitis.
        Br J Dermatol. 1994; 131: 383-396
        • Popescu CM
        • Popescu R
        • Williams HC
        • Forsea D
        Community validation of the UK diagnostic criteria for atopic dermatitis in Romanian schoolchildren.
        Br J Dermatol. 1998; 138: 436-442
        • European Task Force on Atopic Dermatitis
        Severity scoring of atopic dermatitis: the SCORAD Index.
        Dermatology. 1993; 186: 23-31
        • Weiland SK
        • Beasley R
        • Strachan D
        Guidelines for the translation of questionnaires.
        : ISAAC Phase One Co-ordinating committee, Münster, Germany1993
        • Williams HC
        Inflammatory skin diseases I: atopic dermatitis.
        in: The challenge of dermato-epidemiology. : CRC Press Inc, Boca Raton1997
        • Ogawa H
        • Yoshiike T
        A speculative view of atopic dermatitis: barrier dysfunction in pathogenesis.
        J Derm Sci. 1993; 5: 197-204
        • Kay J
        • Gawkrodger DJ
        • Mortimer MJ
        • et al.
        The prevalence of childhood atopic eczema in a general population.
        J Am Acad Dermatol. 1994; 30: 35-39
        • Yemaneberhan H
        • Bekele Z
        • Venn A
        • Lewis S
        • Parry E
        • Britton J
        Low prevalence of wheeze and asthma, and the disassociation of their relation with atopy in urban and rural areas of Ethiopia.
        Lancet. 1997; 350: 85-90
        • Burney P
        • Malmberg E
        • Chinn S
        • Jarvis D
        • Luczynska C
        • Lai E
        The distribution of total and specific serum IgE in the European Community Respiratory Health Survey.
        J Allergy Clin Immunol. 1997; 99: 314-322
        • Macharia WM
        • Anabwani GM
        • Owili DM
        Clinical presentation of atopic dermatitis in Negroid children.
        Afr J Med Sci. 1993; 22: 41-44
        • Lewis S
        ISAAC—a hypothesis generator for asthma?.
        Lancet. 1998; 351: 1220-1221
        • Williams HC
        So how do I define atopic eczema?—a practical manual for researchers wishing to define atopic eczema.
        : University of Nottingham, Department of Dermatology, Nottingham1997
        • International Study of Asthma and Allergies in Childhood
        Phase II Modules.
        : University of Münster, Münster1998